InvestorsHub Logo
Followers 469
Posts 23383
Boards Moderated 0
Alias Born 02/05/2004

Re: None

Saturday, 07/09/2016 11:42:36 AM

Saturday, July 09, 2016 11:42:36 AM

Post# of 130502
No mention of Bobby Farrell's pillaging of Amarantus in his new job description as President & CFO of Kalytera Theraputics

Too embarrassed that the real truth to be known?

His present job description is the excat same one that was on AMBS's web site when he was hired - how utterly pathetic

http://kalytera.co/robert-farrell-appointment/

Kalytera Appoints Robert Farrell as President and Chief Financial Officer

Mr. Farrell has held senior positions with publicly listed companies, including Titan Pharmaceuticals, where he served as President and CEO from 2008 to 2009 and as Chief Financial Officer from 1996 to 2008. Mr. Farrell raised over $390M while at Titan via public equity and non-dilutive financings, including seven corporate partnerships. Previously, Mr. Farrell served as CFO, Corporate Group Vice President and General Counsel at Fresenius USA and Fresenius Medical Care, where he completed six corporate partnerships and M&A transactions totaling over $4B. Mr. Farrell received a law degree (J.D.) from the University of California’s Hastings College of Law and is a member of the California State Bar.

“After a search for a financial executive with a broad range of experience and strategic acumen, we are delighted that Bob has joined the Kalytera team,” said David Stefansky, Co-Founder and Chairman of Kalytera’s Board of Directors. “Bob brings to Kalytera an impressive track record of achievement and a range of financial management and strategic planning experience, especially in the areas of capital resource development and partnering.”

“This is an exciting time to join Kalytera as the company focuses on developing its portfolio of novel therapeutics,” said Mr. Farrell. “I look forward to working with the Kalytera team to maximize our opportunities for success as we work together to meet unmet patient needs in the field of bone health.”